Collegium Pharmaceutical, Inc.
COLL
$36.05
$1.253.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.31% | 237.51% | -38.88% | -91.28% | -60.75% |
| Total Depreciation and Amortization | -0.21% | 35.35% | 59.61% | 59.63% | 59.35% |
| Total Amortization of Deferred Charges | -10.39% | 11.18% | -15.52% | -23.20% | -27.46% |
| Total Other Non-Cash Items | 652.98% | -190.62% | -35.41% | 309.52% | -143.41% |
| Change in Net Operating Assets | 101.27% | 86.70% | -164.50% | -179.63% | 899.67% |
| Cash from Operations | 45.37% | 971.63% | 7.48% | -10.56% | 15.42% |
| Capital Expenditure | -20.88% | 22.95% | 75.93% | -40.49% | -247.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -73.16% | -263.03% | 67.00% | 49.42% | 55.11% |
| Cash from Investing | -70.63% | 87.60% | 67.27% | 46.60% | 53.13% |
| Total Debt Issued | 4,679.49% | -- | -- | -- | 88.30% |
| Total Debt Repaid | -3,536.32% | 90.19% | 79.58% | 64.77% | 64.77% |
| Issuance of Common Stock | 469.36% | 269.68% | -94.61% | -54.88% | -94.66% |
| Repurchase of Common Stock | 96.60% | -578.87% | 37.54% | 17.72% | -0.28% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -88.30% |
| Cash from Financing | 47.14% | -109.94% | 57.65% | 53.39% | 39.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 156.79% | 130.07% | 137.97% | 298.14% | 261.37% |